Search

everythinglearnresearchcommunity

for

Search:↓

Stress may trigger hair loss by affecting immune protection in hair follicles.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

A woman developed vitiligo from repeated eyebrow microblading.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

Some people with primary cicatricial alopecia also have inflammatory bowel disease, suggesting a possible connection.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Alopecia areata is complex, often recurring, and needs personalized treatment, especially with other health issues.

People with Down syndrome have a higher risk of skin disorders and need better screening and treatment.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

Enhancing melanin's energy generation may help treat alopecia areata.

Hair disorders need a holistic approach, including medical, cosmetic, and psychological support.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

A microneedle patch can help regrow hair by restoring immune balance in hair follicles.

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Congenital alopecia areata may have genetic links and topical corticosteroids are an effective treatment.

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.

The study found that steroids and tetracycline helped treat active Lichen planopilaris, and hair transplants were good for later stages.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

Children's hair loss can be caused by various factors and should be treated with appropriate, age-specific methods and psychological support.